← Leaderboards
Herbert W Virgin
Washington University
$43,147,000
Attributed
$50,660,281
Total exposure
33
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $12.9M · FY2005–23$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$144,099,728 · 36
By mechanism
U19$65,407,986 · 7
U54$47,235,376 · 7
R01$29,787,116 · 15
R24$1,576,325 · 1
P60$66,925 · 4
R13$26,000 · 2
Top collaborators
- Douglas Kwon9 shared
- Dan H. Barouch6 shared
- Thaddeus S Stappenbeck5 shared
- Andrew A Lackner2 shared
- Daved H Fremont1 shared
Most similar at Washington University
Same institution · by research overlap
- Christine T Pham$10,070,288
- Samuel H Speck$26,128,328
- David Wang$34,713,611
- William A Frazier$7,571,651
Others in their field
Top investigators on “Virus”
- David Heimbrook · Leidos Biomedical Research, Inc.$512,873,478
- Lawrence Corey · Fred Hutchinson Cancer Center$392,679,667
- Barton F Haynes · Duke University$328,711,626
- Dennis R. Burton · Scripps Research Institute$276,624,892
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$274,342,142
- Richard Webby · St. Jude Children'S Research Hospital$265,067,789
Research focus
VirusPathogenInfectionBaseCollaborationsProgramsGenesImmuneNorovirusProteinsFundingCellsPathogenesisAutophagocytosisIn VivoImmunologyReportingViralPathway InteractionsImmunityLaboratory MouseBacteriaAnimalsNational Institute Of Allergy And Infectious Disease
Grant awards (128)
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2023 · AI · contact PI
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$410,368
U19 · FY2023 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2022 · AI · contact PI
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$637,166
U19 · FY2022 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2021 · AI · contact PI
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$365,842
U19 · FY2021 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$7,381,267
U19 · FY2020 · AI · contact PI
Admin Core - Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$309,111
U19 · FY2020 · AI · contact PI
ConProject-001$73,877
U19 · FY2020 · AI · contact PI
RP3: Targeting ATG gene-dependent immunity for novel anti-infective therapeutics$985,910
U19 · FY2019 · AI · contact PI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection$1,626,624
U19 · FY2018 · AI · contact PI
Impact of the Intestinal Microbiome on HIV/SIV Vaccines$789,065
R01 · FY2018 · OD · contact PI
The enteric microbiome in treated and progressive HIV infection$723,582
R01 · FY2018 · DK
Administrative Core$272,615
U19 · FY2018 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$6,644,235
U19 · FY2017 · AI · contact PI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection$1,276,123
U19 · FY2017 · AI · contact PI
Impact of the Intestinal Microbiome on HIV/SIV Vaccines$812,077
R01 · FY2017 · OD · contact PI
The enteric microbiome in treated and progressive HIV infection$723,582
R01 · FY2017 · DK
Role of CD300 Family in Norovirus Tropism, Persistence, and Immunity$699,874
R01 · FY2017 · AI · contact PI
Inflammation and the vaginal metagenome in HIV acquisition$612,193
R01 · FY2017 · AI
Administrative Core$494,904
U19 · FY2017 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$6,697,676
U19 · FY2016 · AI · contact PI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection$920,338
U19 · FY2016 · AI · contact PI
PRIMATE INFECTIOUS DISEASE RESOURCE (PIDR)$781,600
R24 · FY2016 · OD · contact PI
The enteric microbiome in treated and progressive HIV infection$723,583
R01 · FY2016 · DK
Inflammation and the vaginal metagenome in HIV acquisition$612,771
R01 · FY2016 · AI
Administrative Core$421,804
U19 · FY2016 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$6,435,264
U19 · FY2015 · AI · contact PI
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection$822,472
U19 · FY2015 · AI · contact PI
PRIMATE INFECTIOUS DISEASE RESOURCE (PIDR)$794,725
R24 · FY2015 · OD · contact PI
The enteric microbiome in treated and progressive HIV infection$705,157
R01 · FY2015 · DK
Inflammation and the vaginal metagenome in HIV acquisition$633,994
R01 · FY2015 · AI
Administrative Core$172,293
U19 · FY2015 · AI · contact PI
Autophagy Modulators as Novel Broad-Spectrum Anti-Infective Agents$6,377,610
U19 · FY2014 · AI · contact PI
The enteric microbiome in treated and progressive HIV infection$804,179
R01 · FY2014 · DK
Genes/Pathways for ATG Gene-dependent Inhibition of Viruses & Parasite Infection$774,740
U19 · FY2014 · AI · contact PI
METAGENOMICS OF ENTERIC DISEASE IN SIV-INFECTED AND UNINFECTED MACAQUES$753,932
R01 · FY2014 · OD · contact PI
Inflammation and the vaginal metagenome in HIV acquisition$690,399
R01 · FY2014 · AI
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASE$376,200
R01 · FY2014 · AI · contact PI
Administrative Core$163,946
U19 · FY2014 · AI · contact PI
MRCE for Biodefense and Emerging Infectious Dieseases$6,494,175
U54 · FY2013 · AI · contact PI
Developmental Projects Program$744,208
U54 · FY2013 · AI · contact PI
METAGENOMICS OF ENTERIC DISEASE IN SIV-INFECTED AND UNINFECTED MACAQUES$725,744
R01 · FY2013 · OD · contact PI
Administrative Core$600,704
U54 · FY2013 · AI · contact PI
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASE$353,628
R01 · FY2013 · AI · contact PI
Novel interferon dependent innate antiviral mechanisms$332,266
U54 · FY2013 · AI · contact PI
MRCE for Biodefense and Emerging Infectious Dieseases$7,257,328
U54 · FY2012 · AI · contact PI
METAGENOMICS OF ENTERIC DISEASE IN SIV-INFECTED AND UNINFECTED MACAQUES$771,951
R01 · FY2012 · OD · contact PI
Developmental Projects Program$712,502
U54 · FY2012 · AI · contact PI
Administrative Core$638,579
U54 · FY2012 · AI · contact PI
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASE$376,200
R01 · FY2012 · AI · contact PI
IMMUNITY AND PATHOGENESIS OF A NOVEL NOROVIRUS$374,986
R01 · FY2012 · AI · contact PI
Novel interferon dependent innate antiviral mechanisms$323,326
U54 · FY2012 · AI · contact PI
IMMUNOLOGIC CONTROL OF GAMMAHERPESVIRUS LATENCY$270,317
R01 · FY2012 · CA · contact PI
MRCE for Biodefense and Emerging Infectious Dieseases$7,189,398
U54 · FY2011 · AI · contact PI
METAGENOMICS OF ENTERIC DISEASE IN SIV-INFECTED AND UNINFECTED MACAQUES$805,927
R01 · FY2011 · RR · contact PI
Developmental Projects Program$681,947
U54 · FY2011 · AI · contact PI
Administrative Core$512,876
U54 · FY2011 · AI · contact PI
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASE$376,200
R01 · FY2011 · AI · contact PI
IMMUNITY AND PATHOGENESIS OF A NOVEL NOROVIRUS$374,986
R01 · FY2011 · AI · contact PI
Novel interferon dependent innate antiviral mechanisms$338,164
U54 · FY2011 · AI · contact PI
IMMUNOLOGIC CONTROL OF GAMMAHERPESVIRUS LATENCY$270,317
R01 · FY2011 · CA · contact PI
MRCE for Biodefense and Emerging Infectious Dieseases$7,122,507
U54 · FY2010 · AI · contact PI
Administrative Core$609,410
U54 · FY2010 · AI · contact PI
Developmental Projects Program$560,892
U54 · FY2010 · AI · contact PI
SUSCEPTIBILILTY GENE-VIRUS INTERACTIONS IN INFLAMMATORY BOWEL DISEASE$380,000
R01 · FY2010 · AI · contact PI
IMMUNITY AND PATHOGENESIS OF A NOVEL NOROVIRUS$378,774
R01 · FY2010 · AI · contact PI
Novel interferon dependent innate antiviral mechanisms$350,661
U54 · FY2010 · AI · contact PI
Norovirus Infection of Dendritic Cells and Macrophages$314,034
R01 · FY2010 · AI · contact PI
IMMUNOLOGIC CONTROL OF GAMMAHERPESVIRUS LATENCY$278,677
R01 · FY2010 · CA · contact PI
IMMUNITY AND PATHOGENESIS OF A NOVEL NOROVIRUS$72,299
R01 · FY2010 · AI · contact PI
MRCE for Biodefense and Emerging Infectious Dieseases$7,784,931
U54 · FY2009 · AI · contact PI
MRCE for Biodefense and Emerging Infectious Dieseases$1,911,255
U54 · FY2009 · AI · contact PI
Discovery and characterization of emerging, engineered and unrecognized pathogens$900,702
U54 · FY2009 · AI · contact PI
Developmental Projects Program$534,384
U54 · FY2009 · AI · contact PI
Administrative Core$479,719
U54 · FY2009 · AI · contact PI
IMMUNITY AND PATHOGENESIS OF A NOVEL NOROVIRUS$382,600
R01 · FY2009 · AI · contact PI
Novel interferon dependent innate antiviral mechanisms$334,384
U54 · FY2009 · AI · contact PI
Norovirus Infection of Dendritic Cells and Macrophages$317,206
R01 · FY2009 · AI · contact PI
IMMUNOLOGIC CONTROL OF GAMMAHERPESVIRUS LATENCY$278,677
R01 · FY2009 · CA · contact PI
Novel IFN - Dependent Innate Antiviral Mechanisms$450,842
U54 · FY2008 · AI · contact PI
IMMUNITY AND PATHOGENESIS OF A NOVEL NOROVIRUS$395,600
R01 · FY2008 · AI · contact PI
Discovery of Novel Human Pathogens$370,216
U54 · FY2008 · AI · contact PI
Norovirus Infection of Dendritic Cells and Macrophages$317,206
R01 · FY2008 · AI · contact PI
IMMUNOLOGIC CONTROL OF GAMMAHERPESVIRUS LATENCY$278,677
R01 · FY2008 · CA · contact PI
Regulation of gamma herpesvirus latency and tumorigenesis$340,919
R01 · FY2007 · CA · contact PI
Norovirus Infection of Dendritic Cells and Macrophages$328,747
R01 · FY2007 · AI · contact PI
Immunity and Pathogenesis of a Novel Calicivirus$326,412
R01 · FY2007 · AI · contact PI
Norovirus Infection of Dendritic Cells and Macrophages$355,519
R01 · FY2006 · AI · contact PI
Regulation of Y-herpesvirus latency and tumorigenesis$351,101
R01 · FY2006 · CA · contact PI
Immunity and Pathogenesis of a Novel Calicivirus$336,161
R01 · FY2006 · AI · contact PI
MORPHOLOGY CORE$66,925
P60 · FY2006 · DK · contact PI
Cell Biology of Virus Entry, Replication and Pathogenesis$6,000
R13 · FY2006 · AI · contact PI
Vascular Injury and Atherosclerosis During Herpesvirus *$382,500
R01 · FY2005 · HL
Regulation of Y-herpesvirus latency and tumorigenesis$359,550
R01 · FY2005 · CA
Immunity and Pathogenesis of a Novel Calicivirus$344,250
R01 · FY2005 · AI
T Cell Vaccination Against gamma-herpesvirus Latency$263,378
R01 · FY2005 · CA
ASM Conference on Viral Immune Evasion$20,000
R13 · FY2005 · AI
MORPHOLOGY CORE$0
P60 · FY2005 · DK
Vascular Injury and Atherosclerosis During Herpesvirus *$382,500
R01 · FY2004 · HL
Regulation of Y-herpesvirus latency and tumorigenesis$359,550
R01 · FY2004 · CA
MECHANISM OF GAMMA-HERPESVIRUS DAF/MCP HOMOLOG$346,500
R01 · FY2004 · AI
Immunity and Pathogenesis of a Novel Calicivirus$344,250
R01 · FY2004 · AI
T Cell Vaccination Against gamma-herpesvirus Latency$263,378
R01 · FY2004 · CA
MORPHOLOGY CORE$0
P60 · FY2004 · DK
Vascular Injury and Atherosclerosis During Herpesvirus *$382,500
R01 · FY2003 · HL
Regulation of gamma herpesvirus latency &tumorigenesis$359,550
R01 · FY2003 · CA
MECHANISM OF GAMMA-HERPESVIRUS DAF/MCP HOMOLOG$346,500
R01 · FY2003 · AI
Immunity and Pathogenesis of a Novel Calicivirus$344,250
R01 · FY2003 · AI
Search for Infectious Etiology of Wegener's Disease$294,500
R01 · FY2003 · AI
T Cell Vaccination Against gamma-herpesvirus Latency$267,665
R01 · FY2003 · CA
CORE--MORPHOLOGY$0
P60 · FY2003 · DK
Vascular Injury and Atherosclerosis During Herpesvirus *$382,500
R01 · FY2002 · HL
REGULATION OF GAMMA HERPESVIRUS LATENCY &TUMORIGENESIS$363,851
R01 · FY2002 · CA
MECHANISMS OF VIRUS-INDUCED ELASTIC ARTERITIS$336,520
R01 · FY2002 · HL
MECHANISM OF GAMMA-HERPESVIRUS DAF/MCP HOMOLOG$311,850
R01 · FY2002 · AI
Search for Infectious Etiology of Wegener's Disease$292,600
R01 · FY2002 · AI
T Cell Vaccination Against gamma-herpesvirus Latency$272,340
R01 · FY2002 · CA
MECHANISM OF GAMMA-HERPESVIRUS DAF/MCP HOMOLOG$346,500
R01 · FY2001 · AI
REGULATION OF GAMMA HERPESVIRUS LATENCY &TUMORIGENESIS$331,157
R01 · FY2001 · CA
MECHANISMS OF VIRUS-INDUCED ELASTIC ARTERITIS$317,201
R01 · FY2001 · HL
Search for Infectious Etiology of Wegener's Disease$307,460
R01 · FY2001 · AI
MECHANISMS OF INTERFERON ACTION AGAINST CMV$226,902
R01 · FY2001 · AI
MECHANISM OF GAMMA-HERPESVIRUS DAF/MCP HOMOLOG$347,531
R01 · FY2000 · AI
REGULATION OF GAMMA HERPESVIRUS LATENCY &TUMORIGENESIS$321,513
R01 · FY2000 · CA
MECHANISMS OF VIRUS-INDUCED ELASTIC ARTERITIS$317,201
R01 · FY2000 · HL
Search for Infectious Etiology of Wegener's Disease$257,422
R01 · FY2000 · AI
MECHANISMS OF INTERFERON ACTION AGAINST CMV$220,294
R01 · FY2000 · AI